We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
-0.85%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$4.7B
AUM Growth
-$472M
Cap. Flow
-$338M
Cap. Flow %
-7.2%
Top 10 Hldgs %
35.12%
Holding
103
New
3
Increased
17
Reduced
56
Closed
14

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$68.7M
2
INTC icon
Intel
INTC
+$20.9M
3
RCI icon
Rogers Communications
RCI
+$19.1M
4
ILMN icon
Illumina
ILMN
+$17.1M
5
OTEX icon
Open Text
OTEX
+$14.1M

Sector Composition

Rank Sector Weight
1 Financials 33.12%
2 Communication Services 18.53%
3 Materials 11.51%
4 Healthcare 10.57%
5 Technology 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPRY icon
76
ARS Pharmaceuticals
SPRY
$473M
$311K 0.01%
24,700
MGTX icon
77
MeiraGTx Holdings
MGTX
$1.23B
$307K 0.01%
45,300
MLYS icon
78
Mineralys Therapeutics
MLYS
$2.56B
$262K 0.01%
16,500
DUK icon
79
Duke Energy
DUK
$93.1B
$250K 0.01%
2,050
-2,050
-50% -$234K
MSFT icon
80
Microsoft
MSFT
$3.75T
$239K 0.01%
638
KMB icon
81
Kimberly-Clark
KMB
$33B
$215K ﹤0.01%
1,515
-1,510
-50% -$203K
ERO icon
82
Ero Copper
ERO
$3.51B
$176K ﹤0.01%
+14,500
New +$193K
AURA icon
83
Aura Biosciences
AURA
$725M
$124K ﹤0.01%
21,200
TCRX icon
84
TScan Therapeutics
TCRX
$21.7M
$106K ﹤0.01%
77,100
+40,900
+113% +$88.5K
ALDX icon
85
Aldeyra Therapeutics
ALDX
$88.1M
$99.5K ﹤0.01%
17,300
ETNB
86
DELISTED
89bio
ETNB
$77.8K ﹤0.01%
10,700
HUMA icon
87
Humacyte
HUMA
$156M
$42.3K ﹤0.01%
+24,800
New +$93.1K
PLRX icon
88
Pliant Therapeutics
PLRX
$72.4M
$14K ﹤0.01%
10,400
PROK icon
89
ProKidney
PROK
$376M
$13.9K ﹤0.01%
15,900
ALB icon
90
Albemarle
ALB
$13.9B
-2,475
Closed -$213K
CLS icon
91
Celestica
CLS
$39.9B
-245,843
Closed -$22.7M
DKS icon
92
Dick's Sporting Goods
DKS
$11.6B
-54,220
Closed -$12.4M
GOOGL icon
93
Alphabet (Google) Class A
GOOGL
$4.27T
-1,092
Closed -$207K
MET icon
94
MetLife
MET
$61.7B
-2,900
Closed -$237K
OM icon
95
Outset Medical
OM
$60.3M
-903
Closed -$15K
ORCL icon
96
Oracle
ORCL
$417B
-356,762
Closed -$59.5M
SPY icon
97
State Street SPDR S&P 500 ETF Trust
SPY
$803B
-1,720
Closed -$1.01M
UPS icon
98
United Parcel Service
UPS
$87.2B
-154,369
Closed -$19.5M
URTH icon
99
iShares MSCI World ETF
URTH
$8.19B
-7,400
Closed -$1.15M
VTWO icon
100
Vanguard Russell 2000 ETF
VTWO
$16.9B
-7,000
Closed -$625K

Similar funds

Letko, Brosseau & Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Letko, Brosseau & Associates held 103 positions worth $4.7B, down 9.1% from $5.17B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Letko, Brosseau & Associates withdrew a net $338M in Q1 2025, closing 14 positions and reducing 56 holdings. Its most notable exit was Berry Global Group, Inc., an estimated $61.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 34% a quarter earlier, followed by Communication Services and Materials.

Against the trend, Letko, Brosseau & Associates opened a new position in Adobe worth $61.4M.

  • Letko, Brosseau & Associates's largest Q1 2025 buy was Adobe: 160,141 shares worth $61.4M.
  • Letko, Brosseau & Associates added most to Intel in Q1 2025, an estimated $20.9M increase.
  • Letko, Brosseau & Associates's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $58.4M.
  • Letko, Brosseau & Associates fully exited Berry Global Group, Inc. in Q1 2025, selling an estimated $61.8M.
  • Letko, Brosseau & Associates's ten largest holdings make up 35% of its $4.7B portfolio in Q1 2025.
  • Letko, Brosseau & Associates opened 3 new positions and closed 14 in Q1 2025.
  • Letko, Brosseau & Associates's portfolio value fell 9.1% quarter-over-quarter to $4.7B.

Based on Letko, Brosseau & Associates's 13F filing for Q1 2025, filed 8 May 2025.